Priority Date: 07.06.12 (US 201261656778P)

CHIMERIC FIBROBLAST GROWTH FACTOR 21 PROTEINS AND METHODS OF USE

  • Application ID: EP13799858
  • Status: GRANT OF PATENT INTENDED

Applicant

Research organisation logo small
Research Organisation

Attorney

Company dna adamson jones
no operation time available
827.64
1 office
active in Legal Services

Specialization

This patent has the IPC combination A61, C07, and C12 Adamson Jones is specialized in the combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 127 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 07.06.2012 - Priority Date (US 201261656778P)
  • 12.12.2013 - Publication A1 (WO2013184958)
  • 15.04.2015 - Publication A1 (EP2858663)